This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.04490
Share price
0.00%
Change (1 day)
-99.21%
Change (1 year)
Categories
EPS for ViewRay (VRAY)
EPS in 2023 (TTM): -$0.98
According to ViewRay's latest financial reports the company's current EPS (TTM) is -$1.08. In 2022 the company made an earnings per share (EPS) of -$1.04 an increase over its 2021 EPS that were of -$1.20.
EPS history for ViewRay from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.98 | -6.27% |
| 2022 | -$1.04 | -13.43% |
| 2021 | -$1.20 | -9.46% |
| 2020 | -$1.33 | -37.29% |
| 2019 | -$2.12 | 21.65% |
| 2018 | -$1.74 | -23.02% |
| 2017 | -$2.26 | -0.79% |
| 2016 | -$2.28 | |
| 2014 | -$0.009019 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$1.08 | 0.00% | 🇺🇸 USA |
 | $1.33 | -223.33% | 🇺🇸 USA |
 | -$3.14 | 191.67% | 🇮🇱 Israel |